Filing Manager
Advantech Capital L.P.
Reporting Manager
Advantech Capital L.P.
Symbol
SVA
Shares outstanding
71,884,803 shares
Disclosed Ownership
5,851,423 shares
Ownership
8.1%
Form type
SCHEDULE 13D
Filing time
25 Mar 2025, 10:48:59 UTC
Date of event
18 Mar 2025
Next filing
10 Apr 2025

Sponsored

Quoteable Key Fact

"Advantech Capital L.P. disclosed 8.1% ownership in SINOVAC BIOTECH LTD. Common Shares (SVA) on 18 Mar 2025."

Quick Takeaways

  • Advantech Capital L.P. filed SCHEDULE 13D for SINOVAC BIOTECH LTD. Common Shares (SVA).
  • Disclosed ownership: 8.1%.
  • Date of event: 18 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 25 Mar 2025, 10:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Advantech Capital L.P. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory 0001650757
Advantech Capital Partners Ltd. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory
Green Vision Partners Limited 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Director
Prime Success, L.P. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory